Authors

  1. Aschenbrenner, Diane S. MS, RN

Abstract

* Akynzeo, a combination of two drugs (netupitant and palonosetron), has been approved to prevent nausea and vomiting in patients undergoing cancer chemotherapy.

 

* The most common adverse effects are headache, asthenia, dyspepsia, fatigue, constipation, and erythema. Patients should be monitored for symptoms of serotonin syndrome.